Product Information
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0787 per ML under NDC 64980064503. Its NADAC has been published 52 times since Oct 8, 2025.
FDA first approved this application on Dec 31, 2007. Its Orange Book therapeutic-equivalence code is AN.
Strength
3; .5 mg/3mL; mg/3mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980064503
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATE; IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076749FDA Approved
12/31/2007
TE Code
AN
On Market Since
3/14/2025
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has been published 52 times since Oct 8, 2025, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0787 per ML |
|---|---|
| All-time high | $0.0926 (Dec 10, 2025) |
| All-time low | $0.0787 (Sep 23, 2026) |
| 52-week high | $0.0926 |
| 52-week low | $0.0787 |
| Median price | $0.0884 |
| Average price | $0.0877 |
| Largest weekly change | -3.1% (Aug 19, 2026) |
| Weeks tracked | 52 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium Bromide and Albuterol Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, manufactured by Rising Pharma Holdings Inc., is $0.0787 per ML (NDC 64980064503), effective Sep 30, 2026.
How has the price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has declined 12.8%. It has been tracked across 52 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
Since Oct 8, 2025, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has ranged from a low of $0.0787 (Sep 23, 2026) to a high of $0.0926 (Dec 10, 2025), with a median of $0.0884 per ML.
Are there cheaper alternatives to IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, is $0.0723 per ML — about 8% below IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML.
Who manufactures IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML (NDC 64980064503) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.